HAWTHORNE, N.Y., Sept. 13, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company”) (Nasdaq:TARO) today announced that the Nasdaq Listing Qualifications Panel (the “Panel”) has determined to continue the listing of the Company’s shares on The Nasdaq Global Select Market, subject to certain conditions.
